Palm Beach, FL, August 24, 2020 – The Now Corporation (OTC:NWPN) is pleased to announce that it has signed a letter of intent with a diagnostic center. The aim is to perform neurological studies using state-of-the-art imaging technology to measure brain activity by detecting changes associated with blood flow when CBD compounds are introduced to the human body. The goal of the imaging data analysis is to detect correlations between brain activation in subjects either non-tasked or given tasks to perform during the scan with CBD compounds present. It also aims to discover correlations with cognitive states after CBD compounds are introduced to the subject.
The Now Corporation will develop a protocol for each study, for the diagnostic center imaging operators to follow. The study will also include blood draw findings that go along with imaging analyses. The diagnostic center will allow The Now Corporation to schedule human subjects to achieve imaging needs, utilizing the diagnostic center staff to operate the equipment and supply the corresponding results with a detailed analysis.
“This is uncharted territory when it comes to research. We are opening the door to a promising path for future research. CBD advertisements can also mislead consumers due to vague or false claims, we will uncover the answers for the safety of life and more importantly, to eventually assess the efficacy and safety of some products that we have a direct interest in, ” states Ken Williams, CEO of The Now Corporation.
Updates will be forthcoming
The Now Corporation is a publicly traded, bio-pharmaceutical research company focused on the research, education and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purpose, while focusing on pursuing business opportunities in the growing medical and recreational marijuana sector. Through its acquired assets, The Now Corporation is seeking to invest in our businesses associated with the growing, marketing, research and development, training, distribution and retail sale of scientific-grade medicinal cannabis, both in the United States and Canada. At The Now Corporation, we unlock and advance medicine for human life around the world, at every stage of life.
For further information, please contact:
Chief Executive Officer
The Now Corporation
Legal Notice Regarding Forward-Looking Statements:
This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. That includes the possibility that the business outlined in this press release cannot be concluded for some reason. That could be as a result of technical, installation, permitting or other problems that were not anticipated. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of The Now Corporation to be materially different from the statements made herein. Except for any obligation under the U.S. federal securities laws, The Now Corporation undertakes no obligation to publicly update any forward-looking statement as a result of new information, future events or otherwise.